Professor, group leader, and deputy head at the Institute of Biomedicine.

More than 30 years of experience as a researcher in gene transfer and retinal gene therapy. This includes the development and application of AAV- and LV-based vectors, with a focus on efficient delivery to retinal cells and the treatment of acquired and inherited retinal diseases. In recent years, there has been a strong focus on developing, testing, and applying multiple retinal gene therapies based on technologies such as RNAi and CRISPR/Cas9.

Research group leader with a vision to develop gene therapy for the treatment of retinal diseases and enhance research-based teaching.

As Deputy Head of Department, I actively contribute to the strategic development of the Department of Biomedicine.

This ambition is realized through the following focus areas:

• Promote the development of gene therapy-based treatments through collaborations and advanced technology.
• Integrate new knowledge in personalized medicine to educate future researchers and clinicians.
• Strengthen partnerships with leading institutions and industry to advance translational research.
• Ensure access to advanced laboratories and technology for experimental and clinical studies.
• Attract and develop researchers through career programs and an inspiring research environment.